For the Inventor, By the Inventor

Enter assignee name

Los Angeles, CA, United States of America

Neurosigma, Inc.

USPTO Granted Patents = 10

CIPO Patents = 2

EPO Patents = 5

Trademarks = 5

Forward Citations = 186

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Ian A Cook (6 out of 24 patents)

Leon Ekchian (6 out of 10 patents)

Christopher M DeGiorgio (5 out of 16 patents)

4. Colin Kealey (4 out of 18 patents)

5. Patrick R Miller (4 out of 14 patents)

6. Alejandro Covalin (1 out of 24 patents)

7. Antonio A F Desalles (1 out of 1 patent)

8. Alessandra Gorgulho (1 out of 1 patent)

9. Antonio Afonso Ferreira De Salles (1 out of 1 patent)

10. Christopher M Degiorgio (3 patents)

11. Antonio Desalles (0 patent)

12. Patrick Miller (0 patent)

13. Antonio Desalles (0 patent)

14. Patrick Miller (0 patent)

15. Antonio AF Desalles (0 patent)

10 patents: Sort by Forward Citations

1. 10537729 - Trigeminal neurostimulation based upon pulse counting and chronobiology (2020-01-21),

2. 10525254 - Cutaneous electrode (2020-01-07),

3. 10195435 - Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders (2019-02-05),

4. 10035013 - Subcutaneous electrodes for cranial nerve stimulation (2018-07-31),

5. 10016601 - Pulse generator for cranial nerve stimulation (2018-07-10),

6. 9731127 - Modulation of autonomic nervous system activity and integrated electrode assemblies for trigeminal neurostimulation (2017-08-15),

7. 9675794 - Cutaneous electrode (2017-06-13),

8. 9511223 - Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders (2016-12-06),

9. 8958880 - Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders (2015-02-17),

10. 8257684 - Methods for identifying and targeting autonomic brain regions (2012-09-04),

Neurosigma, Inc. is a medical technology company focused on developing non-invasive neuromodulation therapies for neurological and neuropsychiatric disorders. Their flagship product, the Monarch eTNS System, is FDA cleared for the treatment of ADHD and is also being studied for other conditions such as epilepsy and depression.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

10 Patents

#188 in Los Angeles, CA

#6,885 in California

#28,957 in US

#54,287 in the World

Los Angeles, CA, United States of America

Neurosigma, Inc.

Forward Citations = 186

9 inventors:

Ian A Cook (6 out of 24 patents)

Leon Ekchian (6 out of 10 patents)

Christopher M DeGiorgio (5 out of 16 patents)

4. Colin Kealey (4 out of 18 patents)

5. Patrick R Miller (4 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…